VILDIABATE M 850
Metformin (850mg)SR, Vildagliptin (50mg)
VILDIABATE M 850 contains Metformin (850mg) SR, a sustained-release formulation, and Vildagliptin (50mg), a DPP-4 inhibitor. This combination provides a robust approach to managing type 2 diabetes.
Therapeutic
Uses
Primary Indication: Effective for patients with type 2 diabetes requiring better glycemic control.
Enhanced Efficacy: Addresses multiple pathophysiological defects in diabetes management.
Recommended Dosage
Standard Dosing: Typically, one tablet daily with food to enhance absorption and reduce gastrointestinal side effects.
Tailored Regimen: Dosage adjustments based on individual patient needs and tolerance.
Potential
Side Effects
Common Reactions:
Gastrointestinal disturbances such as nausea, vomiting, and diarrhea. Other side effects include headaches and upper respiratory tract infections.
Serious Risks: Rare but serious side effects include lactic acidosis and acute pancreatitis. Monitoring is essential.
Advantages
Synergistic Effect: Combining Metformin's insulin-sensitizing effects with Vildagliptin's incretin enhancement offers superior blood sugar control.
Convenience and Compliance: Simplifies treatment regimen, leading to better patient adherence and outcomes.
Safety Precautions
Renal Monitoring: Essential due to Metformin's renal excretion. Regular kidney function tests are recommended.
Hepatic Monitoring: Liver function should be monitored due to the risk of hepatic impairment with Vildagliptin.
Hypoglycemia: Generally low risk but should be monitored if used with other anti-diabetic medications.
Pricing Information
Cost: Varies depending on the pharmacy and insurance coverage.
Accessibility: Available in most pharmacies with a prescription. Online options also available for convenience.
Conclusion
VILDIABATE M 850, combining Metformin (850mg) SR and Vildagliptin (50mg), provides a comprehensive and effective option for managing type 2 diabete Steris Healthcare Pvt Ltd, operating as Sterispharma since its founding by expert professionals in the pharmaceutical industry in February 2018, is based in Navi Mumbai. The company is certified by WHO, GMP, and ISO, emphasizing its commitment to quality and safety. Sterispharma focuses on providing high-quality drugs at affordable prices throughout India, adhering strictly to WHO guidelines. Offering the convenience of an online pharmacy, customers can easily purchase medicines with home delivery options available. Sterispharma's mission is to supply a broad range of healthcare products to meet the diverse needs of the medical community. From advanced treatments and medications for rare conditions to essential health necessities, Sterispharma aims to serve the extensive demands of the healthcare industry. You can order medicines from Sterispharma through their websites, sterisonline and sterispharma. Their extensive product lineup includes treatments for Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology.
For further information
Email: info@sterispharma.com / contact@sterispharma.com
Call/WhatsApp: 7877551268, 7849827488
